Clinical Trial Supply and Logistics Market for Pharma 2026-2036

The global Clinical Trial Supply and Logistics Market for Pharma is projected to grow at a CAGR of 8.7% by 2036

SKU: PHA1395 Categories: Contract Services, Popular Reports Code: PHA1395Pages: 367

Download Sample Form

"*" indicates required fields

Name*

Company*

Designation*

Job Title

Industry

Email*

Phone*

Address*

This field is hidden when viewing the form

Report Title

This field is hidden when viewing the form

Sample url

← Back to category Contract Services

Description

Visiongain has published a new report, Clinical Trial Supply and Logistics Market for Pharma 2026-2036, providing a comprehensive analysis of the global clinical trial supply and logistics market, including market size, growth drivers, competitive positioning, and revenue forecasts across type, phase, temperature, and therapeutic area segments.

The global clinical trial supply and logistics market for pharma is valued at US$7.92bn in 2026 and is forecast to reach US$18.22bn by 2036, at a CAGR of 8.7% over the forecast period.

This growth is driven by rising trial complexity across biologics, cell and gene therapies, and precision medicine, the rapid expansion of decentralised and hybrid trial models, and growing globalisation of clinical research into emerging markets requiring integrated regional supply partners.

Access a Free Sample of This Report

Download a sample to explore:

Market forecasts and segment breakdowns
Competitive and company-level insights
Key trends shaping the market
Trade, policy, and supply chain analysis

Technological Innovation Driving Market Expansion

The growing share of biologics, advanced therapies, and personalised medicines in pharma pipelines is creating stronger demand for temperature-controlled clinical logistics. Unlike traditional small molecules, these products require strict cold-chain handling across 2 to 8 degrees Celsius, frozen, ultra-frozen, or cryogenic conditions, where any deviation can compromise product stability, patient safety, and trial validity.

In response, CROs and specialist logistics providers are expanding cryoshipper fleets, digital orchestration platforms, and end-to-end monitoring capabilities to strengthen traceability and maintain product integrity across global clinical supply chains. Real-time temperature monitoring, validated packaging, qualified storage, and robust contingency planning are becoming standard requirements rather than premium services.

On 10 June 2026, X-Therma commercially launched its XT-NoVo and TimeSeal platform, an end-to-end biopreservation solution enabling ice-free, DMSO-free sub-zero preservation and transportation of high-value biologics. This helps extend product viability while supporting more reliable cold-chain logistics for advanced therapies across clinical supply networks globally.

Trade, Policy & Supply Chain Dynamics

U.S. trade tariffs could increase the operating cost and planning complexity of global clinical trial supply chains, particularly where investigational medicinal products, comparators, packaging materials, temperature-controlled containers, and laboratory kits move across borders.
The impact would be strongest for multi-country trials involving frequent cross-border shipments between the U.S., Europe, China, India, and other major pharma hubs, where even modest cost increases can affect depot strategy and sponsor budgets.
Sponsors may need to reassess sourcing locations, use regional depots more actively, and hold higher safety stock to reduce exposure to customs delays or cost volatility.
Tariffs are unlikely to reduce clinical trial activity materially, as drug development timelines and regulatory commitments remain critical. The market impact is expected to be operational rather than demand-destructive, encouraging greater regionalisation and more resilient clinical supply models.

Commercial Impact

Cost pressure: Tariffs on pharmaceutical inputs, laboratory equipment, packaging components, and specialised logistics materials are indirectly raising operational costs throughout the clinical supply chain
Supply chain shifts: Sponsors are placing greater emphasis on supply chain diversification, regional sourcing, and localised inventory management to minimise cross-border exposure and customs risk
Depot strategy: Logistics providers are expanding regional depot networks, strengthening customs and trade compliance capabilities, and optimising distribution routes to maintain reliable trial operations
Competitive positioning: Providers with strong trade compliance, bonded warehousing, and regional distribution networks are better positioned to support sponsors navigating a more complex cost and customs environment

Company Intelligence

The clinical trial supply and logistics market is characterised by a mix of global CROs, specialist clinical supply organisations, integrated logistics providers, and CDMO-adjacent companies competing across cold-chain capability, depot network scale, and end-to-end service integration.

Leading companies including Thermo Fisher Scientific, IQVIA, Almac Group, PCI Pharma Services, and World Courier are strengthening their positions through capacity investment, digital platform development, and expansion of direct-to-patient and regional supply capabilities.

Competition is increasingly defined by:

Cold-chain infrastructure and cryogenic logistics capability for advanced therapy programmes
Direct-to-patient fulfilment and home healthcare coordination capability
Regional depot network depth and customs compliance expertise across emerging markets
Digital integration across forecasting, chain-of-custody visibility, and real-time temperature monitoring

This report analyses how competitive positioning is evolving across 18 leading companies, identifying where value is being created and how strategies are expected to shift over the forecast period.

Key Questions Answered

What is the projected size of the clinical trial supply and logistics market by 2036?
Which segments and regions will drive growth?
How will decentralised trial models and cold-chain complexity shape the competitive landscape?
What is the impact of U.S. trade tariffs on cross-border supply chain operations?
Who are the leading companies and how will their positions evolve?

Report Scope and Data Coverage

Global clinical trial supply and logistics market analysis
Revenue forecasts to 2036
Segment-level modelling across type, phase, temperature, and therapeutic area
Regional and national market forecasts across five regions and 26 leading national markets
Competitive intelligence on 18 leading companies

Includes both quantitative forecasting and qualitative strategic analysis, covering technology, competition, policy, and supply chain dynamics.

Segmentation Framework

By Type

CTS Manufacturing
CTS Logistics & Distribution
CT Supply Chain Management
CTS Packaging & Storage

By Phase

Preclinical
Phase I
Phase II
Phase III
Phase IV
Post Launch

By Temperature

Ambient (15 to 25°C)
Refrigerated (2 to 8°C)
Frozen (0 to -20°C)
Cryogenic (-20 to -150°C)

By Therapeutic Area

Oncology
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Dermatology
Ophthalmology
Other Therapeutic Areas

Geographic Coverage

North America

U.S.
Canada

Europe

Germany
UK
France
Italy
Spain
Netherlands
Switzerland
Rest of Europe

Asia Pacific

Japan
China
India
Australia
South Korea
South-East Asia
Rest of Asia Pacific

Latin America

Brazil
Mexico
Argentina
Colombia
Rest of Latin America

MEA

GCC
South Africa
Rest of MEA

Need industry data? Please contact us today.

Company Intelligence Coverage

This report includes detailed profiles of 18 leading companies, including:

Almac Group
Catalent, Inc.
Charles River
Clinigen Limited
Eurofins Scientific
Fortrea
ICON plc
IQVIA Inc.
Labcorp
Medpace
Myonex
Parexel International Corporation
PCI Pharma Services (PCI)
Pharmaron
Sharp Services LLC
Syneos Health
Thermo Fisher Scientific Inc.
WuXi AppTec

Each profile includes:

Business overview
Financial and market positioning
Product and technology capabilities
Strategic outlook

Bespoke Intelligence & Customisation

Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements.

This includes:

Custom market segmentation and forecasts
Competitive benchmarking and strategy analysis
Policy and regulatory impact assessment
Supply chain and sourcing intelligence
Scenario modelling including tariffs and geopolitical risk

Speak to our team about bespoke requirements

Why This Market Intelligence Matters

The clinical trial supply and logistics market is evolving rapidly, driven by rising trial complexity, cold-chain demand growth, and the expanding adoption of decentralised and direct-to-patient delivery models.
Organisations that understand these dynamics will be better positioned to capture high-value outsourcing opportunities, manage operational risk, and strengthen competitive positioning.
Purchase the Clinical Trial Supply and Logistics Market for Pharma 2026-2036 to access the complete dataset, forecasts, and competitive analysis.

Access the Full Forecast and Competitive Analysis

Purchase the Clinical Trial Supply and Logistics Market for Pharma 2026-2036 to access the complete dataset, forecasts, and competitive analysis.

Download sample or contact us for enterprise access

For enterprise licensing, customised segmentation or analyst briefings, contact Visiongain directly at contactus@visiongain.com

Government Registration
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Growth in Biologics and Gene Therapies
3.3.1.2 Growing Demand for Cold Chain Temperature Controlled Logistics
3.3.1.3 Rise in Outsoucing of Trial Supply Functions
3.3.1.4 Move Towards Decentralized / Virtual Clinical Trials
3.3.1.5 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
3.3.1.6 Increasing Adoption of Integrated Clinical Trial Supply Management Solutions
3.3.2 Market Restraining Factors
3.3.2.1 Clinical Trial and Medical Cold Chain Logistics
3.3.2.2 Man-made or Natural Disruption in Transportation
3.3.3 Market Opportunities
3.3.3.1 AI and Machine Learning are Evolving with More Data
3.3.3.3 Big Companies are Driving the Market
3.4 U.S. Tariffs: What’s the Impact on Global Clinical Trial Supply and Logistics for Pharma Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.3 Why V-Shaped Recovery?
3.4.3.1 Impact from Tariffs
3.4.3.2 Market Dynamics and Demand Recovery
3.4.3.3 Policy and Funding Support
3.4.3.4 Timeframe for Recovery
3.4.4 U-Shaped Recovery Scenario
3.4.4.1 Why U-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 L Shaped Recovery Scenario
3.4.5.1 Why L-Shaped Recovery?
3.4.5.2 Impact from Tariffs
3.4.5.3 Market Dynamics and Demand Recovery
3.4.5.4 Policy and Funding Support
3.4.5.5 Timeframe for Recovery
3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2026–2031) and Long-term (2026–2036) Planning?
3.4.7 Impact of U.S. and China Trade War on Clinical Trial Supply and Logistics for Pharma Market
3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.5 Porter’s Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Competitive Rivalry
3.5.4 Threat from Substitutes
3.5.5 Threat of New Entrants
3.6 PEST Analysis

4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
4.1 Key Findings
4.2 Type Segment: Market Attractiveness Index
4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
4.4 CTS Manufacturing
4.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2026 & 2036 (%)
4.5 CTS Logistics & Distribution
4.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2026 & 2036 (%)
4.6 CT Supply Chain Management
4.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
4.6.2 Market Share by Region, 2026 & 2036 (%)
4.7 CTS Packaging & Storage
4.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
4.7.2 Market Share by Region, 2026 & 2036 (%)

5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
5.4 Preclinical
5.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2026 & 2036 (%)
5.5 Phase I
5.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2026 & 2036 (%)
5.6 Phase II
5.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2026 & 2036 (%)
5.7 Phase III
5.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2026 & 2036 (%)
5.8 Phase IV
5.8.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2026 & 2036 (%)
5.9 Post Launch
5.9.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2026 & 2036 (%)

6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Temperature
6.1 Key Findings
6.2 Temperature Segment: Market Attractiveness Index
6.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
6.4 Ambient (15 – 25°C)
6.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2026 & 2036 (%)
6.5 Refrigerated (2 – 8°C)
6.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2026 & 2036 (%)
6.6 Frozen (0 – -20°C)
6.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2026 & 2036 (%)
6.7 Cryogenic (-20 – -150°C)
6.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2026 & 2036 (%)

7 Clinical Trial Supply and Logistics for Pharma Market Analysis by Therapeutic Area
7.1 Key Findings
7.2 Therapeutic Area Segment: Market Attractiveness Index
7.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
7.4 Oncology
7.4.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2026 & 2036 (%)
7.5 Infectious Diseases
7.5.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2026 & 2036 (%)
7.6 Cardiovascular Diseases
7.6.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.6.2 Market Share by Region, 2026 & 2036 (%)
7.7 Autoimmune Diseases
7.7.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.7.2 Market Share by Region, 2026 & 2036 (%)
7.8 Dermatology
7.8.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.8.2 Market Share by Region, 2026 & 2036 (%)
7.9 Ophthalmology
7.9.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.9.2 Market Share by Region, 2026 & 2036 (%)
7.10 Other Therapeutic Areas
7.10.1 Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
7.10.2 Market Share by Region, 2026 & 2036 (%)

8 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast

9 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
9.1 Key Findings
9.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
9.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
9.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
9.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
9.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
9.7 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
9.8 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
9.9 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
9.10 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis

10 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
10.1 Key Findings
10.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
10.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
10.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
10.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
10.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
10.7 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
10.8 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
10.9 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
10.10 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
10.11 France Clinical Trial Supply and Logistics for Pharma Market Analysis
10.12 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
10.13 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
10.14 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
10.15 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
10.16 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
10.17 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis

11 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
11.1 Key Findings
11.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
11.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
11.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
11.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
11.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
11.7 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
11.8 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
11.9 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
11.10 China Clinical Trial Supply and Logistics for Pharma Market Analysis
11.11 India Clinical Trial Supply and Logistics for Pharma Market Analysis
11.12 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
11.13 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
11.14 South East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
11.15 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis

12 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
12.1 Key Findings
12.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
12.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
12.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
12.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
12.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
12.7 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
12.8 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
12.9 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
12.10 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
12.11 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
12.12 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
12.13 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis

13 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
13.1 Key Findings
13.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
13.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2026, 2031 & 2036 (US$ Billion)
13.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
13.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
13.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
13.7 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Temperature
13.8 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Therapeutic Area
13.9 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
13.10 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
13.11 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis

14 Company Profiles
14.1 Catalent, Inc.
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2022-2024
14.1.3.2 Regional Market Shares, 2024
14.1.4 Service Benchmarking
14.1.5 Strategic Outlook
14.2 Thermo Fisher Scientific Inc. (PPD)
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2022-2025
14.2.3.2 R&D, 2022-2025
14.2.3.3 Regional Market Shares, 2025
14.2.3.4 Business Segment Market Shares, 2025
14.2.4 Service Benchmarking
14.2.5 Strategic Outlook
14.3 ICON plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Revenue, 2022-2025
14.3.3.2 Regional Market Shares, 2025
14.3.4 Service Benchmarking
14.3.5 Strategic Outlook
14.4 Eurofins Scientific
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2022-2025
14.4.3.2 Regional Market Shares, 2025
14.4.3.3 Business Segment Market Shares, 2025
14.4.4 Services Offered
14.4.5 Strategic Outlook
14.5 Almac Group
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Service Benchmarking
14.5.4 Strategic Outlook
14.6 Parexel International Corporation
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Service Benchmarking
14.6.4 Strategic Outlook
14.7 PCI Pharma Services (PCI)
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Service Benchmarking
14.7.4 Strategic Outlook
14.8 IQVIA Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2022-2025
14.8.3.2 Regional Market Shares, 2025
14.8.3.3 Business Segment Market Shares, 2025
14.8.4 Service Benchmarking
14.8.5 Strategic Outlook
14.9 WuXi AppTec
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2022-2025
14.9.3.2 Regional Market Shares, 2025
14.9.3.3 Business Segment Market Shares, 2025
14.9.4 Service Benchmarking
14.9.5 Strategic Outlook
14.10 Charles River Laboratories
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2022-2025
14.10.3.2 Regional Market Shares, 2025
14.10.3.3 Business Segment Market Shares, 2025
14.10.4 Service Benchmarking
14.10.5 Strategic Outlook
14.11 Pharmaron
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2022-2025
14.11.3.2 Regional Market Shares, 2025
14.11.3.3 Business Segment Market Shares, 2025
14.11.4 Service Benchmarking
14.11.5 Strategic Outlook
14.12 Fortrea
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2022-2025
14.12.3.2 Regional Market Shares, 2025
14.12.4 Service Benchmarking
14.12.5 Strategic Outlook
14.13 Medpace
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2022-2025
14.13.3.2 Business Segment Market Shares, 2025
14.13.4 Service Benchmarking
14.14 Sharp Services, LLC
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2022-2024
14.14.4 Service Benchmarking
14.14.5 Strategic Outlook
14.15 Clinigen Limited
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Service Benchmarking
14.15.4 Strategic Outlook
14.16 Syneos Health
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Service Benchmarking
14.16.4 Strategic Outlook
14.17 Labcorp
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2022-2025
14.17.3.2 Regional Market Shares, 2025
14.17.3.3 Business Segment Market Shares, 2025
14.17.4 Service Benchmarking
14.17.5 Strategic Outlook
14.18 Myonex
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Service Benchmarking
14.18.4 Strategic Outlook

15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players

List of Tables
Table 1 Clinical Trial Supply and Logistics for Pharma Market Snapshot, 2026 & 2036 (US$ Billion, CAGR %)
Table 2 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %): “V” Shaped Recovery
Table 3 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %): “U” Shaped Recovery
Table 4 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %): “L” Shaped Recovery
Table 5 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 6 CTS Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 7 CTS Logistics & Distribution Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 8 CT Supply Chain Management Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 9 CTS Packaging & Storage Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 10 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 11 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 12 Phase I Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 13 Phase II Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 14 Phase III Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 15 Phase IV Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 16 Post Launch Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 17 Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 18 Ambient (15 – 25°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 19 Refrigerated (2 – 8°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 20 Frozen (0 – -20°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 21 Cryogenic (-20 – -150°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 22 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 23 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 24 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 25 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 26 Autoimmune Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 27 Dermatology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 28 Ophthalmology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 29 Other Therapeutic Areas Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 30 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 31 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 32 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 33 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 34 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 35 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 36 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 37 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 38 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 39 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 40 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 41 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 42 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 43 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 44 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 45 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 46 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 47 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 48 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 49 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 50 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 51 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 52 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 53 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 54 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 55 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 56 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 57 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 58 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 59 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 60 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 61 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 62 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 63 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 64 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 65 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 66 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 67 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 68 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 69 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 70 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 71 Argentina Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 72 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 73 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 74 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 75 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 76 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 77 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 78 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 79 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 80 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 81 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %, CAGR %)
Table 82 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Catalent, Inc.: Service Benchmarking
Table 84 Catalent, Inc.: Strategic Outlook
Table 85 Thermo Fisher Scientific Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Thermo Fisher Scientific Inc.: Service Benchmarking
Table 87 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 88 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 ICON plc: Service Benchmarking
Table 90 ICON plc: Strategic Outlook
Table 91 Eurofins Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Eurofins Scientific: Services Offered
Table 93 Eurofins Scientific: Strategic Outlook
Table 94 Almac Group: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Almac Group: Service Benchmarking
Table 96 Almac Group: Strategic Outlook
Table 97 Parexel International Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Parexel International Corporation: Service Benchmarking
Table 99 Parexel International Corporation: Strategic Outlook
Table 100 PCI Pharma Services (PCI): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 PCI Pharma Services (PCI): Service Benchmarking
Table 102 PCI Pharma Services (PCI): Strategic Outlook
Table 103 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 IQVIA Inc.: Service Benchmarking
Table 105 IQVIA Inc.: Strategic Outlook
Table 106 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 WuXi AppTec: Service Benchmarking
Table 108 WuXi AppTec: Strategic Outlook
Table 109 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Charles River Laboratories: Service Benchmarking
Table 111 Charles River Laboratories: Strategic Outlook
Table 112 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Pharmaron: Service Benchmarking
Table 114 Pharmaron: Strategic Outlook
Table 115 Fortrea: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Fortrea: Service Benchmarking
Table 117 Fortrea: Strategic Outlook
Table 118 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Medpace: Service Benchmarking
Table 120 Sharp Services, LLC: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Sharp Services, LLC: Service Benchmarking
Table 122 Sharp Services, LLC: Strategic Outlook
Table 123 Clinigen Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Clinigen Limited: Service Benchmarking
Table 125 Clinigen Limited: Strategic Outlook
Table 126 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Syneos Health: Service Benchmarking
Table 128 Syneos Health: Strategic Outlook
Table 129 Labcorp: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Labcorp: Service Benchmarking
Table 131 Labcorp: Strategic Outlook
Table 132 Myonex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Myonex: Service Benchmarking
Table 134 Myonex: Strategic Outlook

List of Figures
Figure 1 Clinical Trial Supply and Logistics for Pharma Market Segmentation
Figure 2 Clinical Trial Supply and Logistics for Pharma Market by Type: Market Attractiveness Index
Figure 3 Clinical Trial Supply and Logistics for Pharma Market by Phase: Market Attractiveness Index
Figure 4 Clinical Trial Supply and Logistics for Pharma Market by Temperature: Market Attractiveness Index
Figure 5 Clinical Trial Supply and Logistics for Pharma Market by Therapeutic Area: Market Attractiveness Index
Figure 6 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Region
Figure 7 Clinical Trial Supply and Logistics for Pharma Market: Market Dynamics
Figure 8 Clinical Trial Supply and Logistics for Pharma Market: Impact Analysis
Figure 9 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Clinical Trial Supply and Logistics for Pharma Market: Porter’s Five Forces Analysis
Figure 16 Clinical Trial Supply and Logistics for Pharma Market: PEST Analysis
Figure 17 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 18 Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 19 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026, 2031, 2036 (%)
Figure 20 CTS Manufacturing Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 21 CTS Manufacturing Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 22 CTS Logistics & Distribution Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 23 CTS Logistics & Distribution Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 24 CT Supply Chain Management Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 25 CT Supply Chain Management Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 26 CTS Packaging & Storage Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 27 CTS Packaging & Storage Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 28 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Type
Figure 29 Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
Figure 30 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026, 2031, 2036 (%)
Figure 31 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 32 Preclinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 33 Phase I Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 34 Phase I Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 35 Phase II Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 36 Phase II Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 37 Phase III Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 38 Phase III Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 39 Phase IV Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 40 Phase IV Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 41 Post Launch Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 42 Post Launch Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 43 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Temperature
Figure 44 Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
Figure 45 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026, 2031, 2036 (%)
Figure 46 Ambient (15 – 25°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 47 Ambient (15 – 25°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 48 Refrigerated (2 – 8°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 49 Refrigerated (2 – 8°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 50 Frozen (0 – -20°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 51 Frozen (0 – -20°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 52 Cryogenic (-20 – -150°C) Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 53 Cryogenic (-20 – -150°C) Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 54 Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index by Therapeutic Area
Figure 55 Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
Figure 56 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026, 2031, 2036 (%)
Figure 57 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 58 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 59 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 60 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 61 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 62 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 63 Autoimmune Diseases Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 64 Autoimmune Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 65 Dermatology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 66 Dermatology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 67 Ophthalmology Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 68 Ophthalmology Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 69 Other Therapeutic Areas Segment Market Forecast by Region, 2026-2036 (US$ Billion, AGR %)
Figure 70 Other Therapeutic Areas Segment Market Share Forecast by Region, 2026 & 2036 (%)
Figure 71 Clinical Trial Supply and Logistics for Pharma Market Forecast by Region 2026, 2031, 2036 (Revenue, CAGR%)
Figure 72 Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Region 2026, 2031, 2036 (%)
Figure 73 Clinical Trial Supply and Logistics for Pharma Market by Region, 2026-2036 (US$ Mn)
Figure 74 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 75 North America Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 76 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 77 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
Figure 78 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 79 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
Figure 80 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
Figure 81 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
Figure 82 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
Figure 83 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
Figure 84 North America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
Figure 85 North America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 86 U.S. Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 87 Canada Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 88 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 89 Europe Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 90 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 91 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
Figure 92 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 93 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
Figure 94 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
Figure 95 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
Figure 96 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
Figure 97 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
Figure 98 Europe Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
Figure 99 Europe Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 100 Germany Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 101 UK Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 102 France Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 103 Italy Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 104 Spain Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 105 Russia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 106 Netherlands Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 107 Switzerland Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 108 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 109 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 110 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 111 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 112 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
Figure 113 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 114 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
Figure 115 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
Figure 116 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
Figure 117 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
Figure 118 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
Figure 119 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
Figure 120 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 121 Japan Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 122 China Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 123 India Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 124 Australia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 125 South Korea Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 126 South East Asia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 127 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 128 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 129 Latin America Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 130 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 131 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
Figure 132 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 133 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
Figure 134 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
Figure 135 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
Figure 136 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
Figure 137 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
Figure 138 Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
Figure 139 Latin America Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 140 Brazil Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 141 Mexico Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 142 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 143 Colombia Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 144 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 145 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
Figure 146 MEA Clinical Trial Supply and Logistics for Pharma Market by Region, 2026, 2031 & 2036 (US$ Billion)
Figure 147 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Country, 2026-2036 (US$ Billion, AGR %)
Figure 148 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Country, 2026 & 2036 (%)
Figure 149 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Type, 2026-2036 (US$ Billion, AGR %)
Figure 150 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Type, 2026 & 2036 (%)
Figure 151 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Phase, 2026-2036 (US$ Billion, AGR %)
Figure 152 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Phase, 2026 & 2036 (%)
Figure 153 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Temperature, 2026-2036 (US$ Billion, AGR %)
Figure 154 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Temperature, 2026 & 2036 (%)
Figure 155 MEA Clinical Trial Supply and Logistics for Pharma Market Forecast by Therapeutic Area, 2026-2036 (US$ Billion, AGR %)
Figure 156 MEA Clinical Trial Supply and Logistics for Pharma Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
Figure 157 GCC Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 158 South Africa Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 159 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Forecast, 2026-2036 (US$ Billion, AGR %)
Figure 160 Catalent, Inc.: Net Revenue, 2022-2024 (US$ Million, AGR %)
Figure 161 Catalent, Inc.: Regional Market Shares, 2024
Figure 162 Thermo Fisher Scientific Inc: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 163 Thermo Fisher Scientific Inc: R&D, 2022-2025 (US$ Million, AGR %)
Figure 164 Thermo Fisher Scientific Inc: Regional Market Shares, 2025
Figure 165 Thermo Fisher Scientific Inc: Business Segment Market Shares, 2025
Figure 166 ICON plc: Revenue, 2022-2025 (US$ Million, AGR %)
Figure 167 ICON plc: Regional Market Shares, 2025
Figure 168 Eurofins Scientific: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 169 Eurofins Scientific: Regional Market Shares, 2025
Figure 170 Eurofins Scientific: Business Segment Market Shares, 2025
Figure 171 IQVIA Inc.: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 172 IQVIA Inc.: Regional Market Shares, 2025
Figure 173 IQVIA Inc.: Business Segment Market Shares, 2025
Figure 174 WuXi AppTec: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 175 WuXi AppTec: Regional Market Shares, 2025
Figure 176 WuXi AppTec: Business Segment Market Shares, 2025
Figure 177 Charles River Laboratories: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 178 Charles River Laboratories: Regional Market Shares, 2025
Figure 179 Charles River Laboratories: Business Segment Market Shares, 2025
Figure 180 Pharmaron: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 181 Pharmaron: Regional Market Shares, 2025
Figure 182 Pharmaron: Business Segment Market Shares, 2025
Figure 183 Fortrea: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 184 Fortrea: Regional Market Shares, 2025
Figure 185 Medpace: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 186 Medpace: Business Segment Market Shares, 2025
Figure 187 Sharp Services, LLC: Net Revenue, 2022-2024 (US$ Million, AGR %)
Figure 188 Labcorp: Net Revenue, 2022-2025 (US$ Million, AGR %)
Figure 189 Labcorp: Regional Market Shares, 2025
Figure 190 Labcorp: Business Segment Market Shares, 2025

List of Companies Profiled in the Report
Almac Group
Catalent, Inc.
Charles River
Clinigen Limited
Eurofins Scientific
Fortrea
ICON plc
Labcorp
Medpace
Myonex
Parexel International Corporation
PCI Pharma Services (PCI)
Pharmaron
Sharp Services LLC
Syneos Health
Thermo Fisher Scientific Inc.
IQVIA Inc.
WuXi AppTec

List of Other Companies Mentioned in the Report
DHL Health Logistics
Marken
Kuehne+Nagel
Cenmed
Curavit
Cytespace Africa Laboratories
DHL Group
ElevateBio
Hilleman Laboratories
Incyte
Kyverna Therapeutics
Merck
MLM Medical Labs
Moderna
Nanoscope Therapeutics
LigaChem Biosciences
Oximio
Samsung Biologics
Sharp Services
Sincronía Logística
SkyCell
Takeda Pharmaceutical
Uniphar
UPS Healthcare
Veeda Group
Wingcopter
Yusen Logistics Group

List of Associations Mentioned in the Report
Association of British Pharmaceutical Industry (ABPI)
Association for Supply Chain Management (ASCM)
Central Drugs Standard Control Organization (CDSCO)
Development and Reform Commission (NDRC)
European Medicines Agency (EMA)
Food and Drug Administration (US FDA)
Indian Drug Manufacturer’s Association (IDMA)
Irish American Business Chamber & Network (IABCN)
Korea Food and Drug Administration (KFDA)
Korea Pharmaceutical Manufacturer’s Association (KPMA)
Medicines and Healthcare Products Regulatory Agency (MHRA)
Medicines Manufacturing Industry Partnership (MMIP)
Ministry of Health, Labour and Welfare (MHLW)
National Institute for Health and Care Research (NIHR)
Pharmaceutical and Medical Devices Agency (PMDA)
World Health Organization (WHO)

Industry Market Reports